Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Measurement of Pulmonary Inflammation Using 18F-NOS Positron Emission Tomography (PET/CT) in E-cigarette Users
NCT03721822Phase 1Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Oct 2018
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 18F-NOS (6 arms), sponsored by University of Pennsylvania. Primary endpoint: Lung inflammation using [18F]NOS PET/CT at 3 years. Started Oct 2018; status: recruiting.
02
Drugs
18F-NOS
Beyond the preview
Go deeper on NCT03721822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03721822.